paxmedica

  1. Sly Saint

    PaxMedica Plans to Initiate Phase 1B Study for PAX-101 (Suramin) in Patients with Long COVID-19 Syndrome

    Study has been approved by the South African Health Authority for individuals with documented COVID-19 infections who develop debilitating physical and neuropsychiatric symptoms that persist for more than 12 weeks after the viral infection has passed - Enrollment is expected to commence in Q1...
    • Sly Saint
    • Thread
    • 2022 clinical trial long covid pax-101 paxmedica post covid-19 syndrome south africa suramin trial
    • Replies: 21
    • Forum: Long Covid news
  2. B

    Suramin as a possible treatment for Autism, ME CFS and Long Covid

    OMF report Treating Autism and ME / CFS: Could One Drug Help Both? by Cort Johnson https://www.omf.ngo/2017/10/19/treating-autism-and-mecfs-could-one-drug-do-both/
Back
Top Bottom